163 related articles for article (PubMed ID: 7406880)
1. Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle.
Libby P; Goldberg AL
Biochem J; 1980 Apr; 188(1):213-20. PubMed ID: 7406880
[TBL] [Abstract][Full Text] [Related]
2. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.
Libby P; Goldberg AL
Science; 1978 Feb; 199(4328):534-6. PubMed ID: 622552
[TBL] [Abstract][Full Text] [Related]
3. Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo.
Bolli R; Cannon RO; Speir E; Goldstein RE; Epstein SE
J Am Coll Cardiol; 1983 Oct; 2(4):671-80. PubMed ID: 6350399
[TBL] [Abstract][Full Text] [Related]
4. The effect of protease inhibitors and decreased temperature on the degradation of different classes of proteins in cultured hepatocytes.
Neff NT; DeMartino GN; Goldberg AL
J Cell Physiol; 1979 Dec; 101(3):439-57. PubMed ID: 528571
[TBL] [Abstract][Full Text] [Related]
5. Effects of microbial proteinase inhibitors on the degradation of endogenous and internalized proteins by rat yolk sacs.
Knowles SE; Ballard FJ; Livesey G; Williams KE
Biochem J; 1981 Apr; 196(1):41-8. PubMed ID: 7306078
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes.
Grinde B; Seglen PO
Biochim Biophys Acta; 1980 Sep; 632(1):73-86. PubMed ID: 7417519
[TBL] [Abstract][Full Text] [Related]
7. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy.
Furuno K; Goodman MN; Goldberg AL
J Biol Chem; 1990 May; 265(15):8550-7. PubMed ID: 2187867
[TBL] [Abstract][Full Text] [Related]
8. Myofibrillar proteinase, cathepsin B, and protein breakdown rates in skeletal muscle from septic rats.
Hall-Angerås M; Hasselgren PO; Dimlich RV; Fischer JE
Metabolism; 1991 Mar; 40(3):302-6. PubMed ID: 2000044
[TBL] [Abstract][Full Text] [Related]
9. The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism.
Furuno K; Goldberg AL
Biochem J; 1986 Aug; 237(3):859-64. PubMed ID: 3099758
[TBL] [Abstract][Full Text] [Related]
10. Burn-induced stimulation of lysosomal enzyme activity in skeletal muscle.
Odessey R
Metabolism; 1986 Aug; 35(8):750-7. PubMed ID: 3526087
[TBL] [Abstract][Full Text] [Related]
11. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.
Gonçalves DA; Silveira WA; Lira EC; Graça FA; Paula-Gomes S; Zanon NM; Kettelhut IC; Navegantes LC
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E123-33. PubMed ID: 21952035
[TBL] [Abstract][Full Text] [Related]
12. The effect of synthetic analogues of chymostatin upon protein degradation in isolated skeletal muscle.
Mulligan MT; Galpin IJ; Wilby AH; Beynon RJ
Biochem J; 1985 Jul; 229(2):491-7. PubMed ID: 3899108
[TBL] [Abstract][Full Text] [Related]
13. Reduction of muscle protein degradation by leupeptin in acutely uremic rats.
Schaefer RM; Teschner M; Peter G; Leibold J; Kulzer P; Heidland A
Miner Electrolyte Metab; 1988; 14(5):308-12. PubMed ID: 3173266
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of epidermal transglutaminase activity by protease inhibitors.
Kawamura H; Strickland JE; Yuspa SH
Cancer Res; 1983 Sep; 43(9):4073-7. PubMed ID: 6135503
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of chymostatin on dystrophic mice.
Komatsu K; Matsui A; Satoh S
Exp Neurol; 1986 Jul; 93(1):110-6. PubMed ID: 3732454
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain-amino-acid-preferring peptidase activity of the lobster multicatalytic proteinase (proteasome) and the degradation of myofibrillar proteins.
Mykles DL; Haire MF
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):285-91. PubMed ID: 7864822
[TBL] [Abstract][Full Text] [Related]
17. Effects of proteinase inhibitors on the cutaneous lesion of Sporothrix schenckii inoculated hairless mice.
Lei PC; Yoshiike T; Ogawa H
Mycopathologia; 1993 Aug; 123(2):81-5. PubMed ID: 8264771
[TBL] [Abstract][Full Text] [Related]
18. The effect of analogues of chymostatin on lysosomal and non-lysosomal components of protein degradation in isolated hepatocytes.
Place GA; Chetland J; Galpin IJ; Beynon RJ
Biochim Biophys Acta; 1987 Aug; 925(2):185-93. PubMed ID: 2887208
[TBL] [Abstract][Full Text] [Related]
19. Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle.
Taillandier D; Aurousseau E; Meynial-Denis D; Bechet D; Ferrara M; Cottin P; Ducastaing A; Bigard X; Guezennec CY; Schmid HP
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):65-72. PubMed ID: 8645234
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors reduce lysosomal acid phospholipase A1 activity in cultured rat hepatocytes.
Schmidt M; Löffler BM; Kunze H
Biochem Int; 1990; 20(2):337-42. PubMed ID: 2317214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
